The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease

Michelle van der Linden*, Kim Meeuwis, Colette van Hees, Eleonora van Dorst, Johan Bulten, Tjalling Bosse, Joanna IntHout, Dorry Boll, Brigitte Slangen, Manon van Seters, Marc van Beurden, Mariette van Poelgeest, Joanne de Hullu

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number178
Number of pages8
JournalJMIR Research Protocols
Volume6
Issue number9
DOIs
Publication statusPublished - Sep 2017

Keywords

  • Paget disease
  • extramammary Paget disease
  • vulvar Paget disease
  • imiquimod
  • INTRAEPITHELIAL NEOPLASIA
  • 5-AMINOLEVULINIC ACID
  • PHOTODYNAMIC THERAPY
  • SURGERY
  • CLASSIFICATION
  • EPIDEMIOLOGY
  • CARCINOMA
  • EXCISION
  • OUTCOMES
  • ORIGIN

Cite this

van der Linden, M., Meeuwis, K., van Hees, C., van Dorst, E., Bulten, J., Bosse, T., IntHout, J., Boll, D., Slangen, B., van Seters, M., van Beurden, M., van Poelgeest, M., & de Hullu, J. (2017). The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Research Protocols, 6(9), [178]. https://doi.org/10.2196/resprot.7503